lobular panniculitis - Health Topics
The New England Journal of Medicine: Panniculitis during Dasatinib Therapy for Imatinib-Resistant Chronic Myelogenous Leukemia We describe two cases of panniculitis apparently caused by dasatinib. In one, management after the diagnosis of the panniculitis allowed dasatinib therapy to be continued. In the first case, a 55-year ...
Understanding the Context
Invasive lobular carcinoma is a type of breast cancer that begins as a growth of cells in the milk-producing glands of the breast. These glands are called lobules. Invasive cancer means that the cancer cells have broken out of the lobule where they began and spread into the breast tissue. Invasive lobular carcinoma (ILC) is a type of breast cancer that starts in the milk-producing and transportation system of your breast.
Image Gallery
Key Insights
Healthcare providers may use the term “lobules” or “terminal duct lobular units” when they describe where this cancer starts. Invasive lobular carcinoma (ILC) is invasive breast cancer that begins in the lobules (milk glands) of the breast and spreads into the surrounding breast tissue. The location where the cancer originates distinguishes ductal vs. lobular breast cancer: Invasive ductal carcinoma begins in milk ducts whereas invasive lobular carcinoma begins in lobules (the milk-producing glands of the breast). Invasive lobular carcinoma is breast cancer that begins in the cells of the mammary glands that make milk, called lobules, and spreads to other parts of the breast.
Related Articles You Might Like:
can you skip a week of semaglutide fitness programs for older adults images of herpes on genital areaFinal Thoughts
Invasive lobular carcinoma has been grouped with ductal carcinoma, but this breast cancer subtype deserves to be studied separately, says Jason Mouabbi, M.D. Here, he shares the unique symptoms, challenges in diagnosis and research that’s aimed to improve treatment.